Mixed community-acquired pneumonia in hospitalised patients

被引:66
作者
de Roux, A
Ewig, S
García, E
Marcos, MA
Mensa, J
Lode, H
Torres, A
机构
[1] Hosp Clin Barcelona, Dept Pulm, Serv Malad Infect, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pulm, Microbiol Serv, E-08036 Barcelona, Spain
[3] Univ Barcelona, Fac Med, Serv Pneumol Allergia Resp, Inst Clin Torax,Inst Invest Biomed August Pi Suny, Barcelona 7, Spain
[4] Augusta Kranken Anstalt Bochum, Klin Pneumol, Bochum, Germany
[5] Abt Pneumol, Lungenklin Heckenshorn, Berlin, Germany
关键词
community-acquired pneumonia; hospitalisation; mixed pneumonia;
D O I
10.1183/09031936.06.00058605
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The role of mixed community-acquired pneumonia (CAP) is controversial. The aim of the present study was to determine the incidence, principal microbial patterns, clinical predictors and course of mixed CAP. The current study included 1,511 consecutive hospitalised patients with CAP. Of these, 610 (40%) patients had an established aetiology. One pathogen was demonstrated in 528 patients and 82 (13%) patients had mixed pneumonia. Cases including CAP, by a pyogenic bacteria and a complete paired serology for "atypicals", revealed that 82 (13%) patients had definite single pyogenic pneumonia and 28 patients (5%) had mixed pyogenic pneumonia. In patients with mixed CAP, Streptococcus pneumoniae was the most prevalent microorganism (44 out of 82; 54%). The most frequent combination was S. pneurnoniae with Haemophilus influenzae (17 out of 82; 21%). Influenza virus A and S. pneumoniae (five out of 28; 18%) was the most frequent association in the mixed pyogenic pneumonia group. No clinical predictors for mixed pneumonias could be identified. Patients with mixed pyogenic pneumonia more frequently developed shock when compared with patients with single pyogenic pneumonia (18 versus 4%). In conclusion, mixed pneumonia occurs in > 10% of cases with community-acquired pneumonia requiring hospitalisation.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 21 条
[11]   Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pneumococcal pneumonia [J].
Kauppinen, MT ;
Saikku, P ;
Kujala, P ;
Herva, E ;
Syrjala, H .
THORAX, 1996, 51 (02) :185-189
[12]   Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients [J].
Lieberman, D ;
Schlaeffer, F ;
Boldur, I ;
Lieberman, D ;
Horowitz, S ;
Friedman, MG ;
Leiononen, M ;
Horovitz, O ;
Manor, E ;
Porath, A .
THORAX, 1996, 51 (02) :179-184
[13]   A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia [J].
Lim, WS ;
Macfarlane, JT .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) :362-368
[14]   Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines [J].
Lim, WS ;
Macfarlane, JT ;
Boswell, TCJ ;
Harrison, TG ;
Rose, D ;
Leinonen, M ;
Saikku, P .
THORAX, 2001, 56 (04) :296-301
[15]   A role for Streptococcus pneumoniae in virus-associated pneumonia [J].
Madhi, SA ;
Klugman, KP .
NATURE MEDICINE, 2004, 10 (08) :811-813
[16]   Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia [J].
Martínez, JA ;
Horcajada, JP ;
Almela, M ;
Marco, F ;
Soriano, A ;
García, E ;
Marco, MA ;
Torres, A ;
Mensa, J .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) :389-395
[17]   Influenza virus neuraminidase contributes to secondary bacterial pneumonia [J].
Peltola, VT ;
Murti, KG ;
McCullers, JA .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (02) :249-257
[18]   Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria [J].
Rosón, B ;
Carratalà, J ;
Dorca, J ;
Casanova, A ;
Manresa, F ;
Gudiol, F .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :158-165
[19]   Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity [J].
Ruiz, M ;
Ewig, S ;
Marcos, MA ;
Martinez, JA ;
Arancibia, F ;
Mensa, J ;
Torres, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :397-405
[20]   Severe community-acquired pneumonia - Risk factors and follow-up epidemiology [J].
Ruiz, M ;
Ewig, S ;
Torres, A ;
Arancibia, F ;
Marco, F ;
Mensa, J ;
Sanchez, M ;
Martinez, JA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :923-929